Company / Operating Income per Share
AMICUS THERAPEUTICS, INC. Operating Income per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
$0.11
FY2025
5-year range
-$0.79 / $0.11
FY2021-FY2025
Trend
+29.4%
vs FY2024
Sector context
#55 of 201
Health Care
What the data says
At $0.11, AMICUS THERAPEUTICS, INC.'s operating income per share ranks #55 of 201 in the Health Care sector. Operating Income per Share has increased for 8 consecutive years, from $-3.10 in FY2017 to $0.11 in FY2025.
Based on SEC 10-K filings.
0.11 in FY2025.
Improved from $-0.27 to $0.11 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#55 of 201 in Health CareTop 27% of 201This company $0.11 Sector average -$28.56
▼
+100.4% above sector average
Key checks
Key Insights
- AMICUS THERAPEUTICS, INC.'s operating income per share has grown for 8 consecutive years.
- In FY2025, operating income per share increased 29.4% year-over-year.
- Ranks #55 out of 201 companies in the Health Care sector.
- Lowest operating income per share in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -1.19 (distress zone, below 1.8 threshold)
- Negative profit margin: -10.6%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.11 | +29.4% |
| FY2024 | $0.08 | +130.8% |
| FY2023 | -$0.27 | +63.9% |
| FY2022 | -$0.76 | +3.5% |
| FY2021 | -$0.79 | +17.4% |
| FY2020 | -$0.95 | +24.5% |
| FY2019 | -$1.26 | +28.5% |
| FY2018 | -$1.77 | +42.9% |
| FY2017 | -$3.10 | -112.9% |
| FY2016 | -$1.45 | -6.6% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026